Audit of data sharing by pharmaceutical companies for anticancer medicines approved by the US food and drug administration

被引：0
|
作者：
Modi, Natansh D. [1 ]
Hopkins, AshleyM. [1 ]
Sorich, Michael J. [1 ]
机构：
[1] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [21] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 1619 - 1632
  • [22] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Liang, Fei
    Zhang, Sheng
    Wang, Qin
    Li, Wenfeng
    BMC CANCER, 2020, 20 (01)
  • [23] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Fei Liang
    Sheng Zhang
    Qin Wang
    Wenfeng Li
    BMC Cancer, 20
  • [24] Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Tibau, Ariadna
    Molto, Consolacion
    Ocana, Alberto
    Templeton, Arnoud J.
    Del Carpio, Luis P.
    Del Paggio, Joseph C.
    Barnadas, Agusti
    Booth, Christopher M.
    Amir, Eitan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (05): : 486 - 492
  • [25] Postmarketing Safety of Vaccines Approved by the US Food and Drug Administration A Cohort Study
    Tau, Noam
    Yahav, Dafna
    Shepshelovich, Daniel
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 445 - +
  • [26] A COMPARISON OF ANTIEPILEPTIC DRUGS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION AND HEALTH CANADA
    Alsharaimy, F.
    Chong, D.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    Eguale, T.
    VALUE IN HEALTH, 2017, 20 (05) : A199 - A199
  • [27] Vaccines, pharmaceutical products, and bioterrorism: Challenges for the US Food and Drug Administration
    Zoon, KC
    EMERGING INFECTIOUS DISEASES, 1999, 5 (04) : 534 - 536
  • [28] Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration
    Hong, Yoon Duk
    Villalonga-Olives, Ester
    Perfetto, Eleanor M.
    VALUE IN HEALTH, 2019, 22 (08) : 925 - 930
  • [29] In Vitro-to-In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
    Yu, Jingjing
    Ragueneau-Majlessi, Isabelle
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 693 - 699
  • [30] Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2020, 180 (08) : 1108 - 1115
12345